Welcome to the UPF Digital Repository

Reduced expansion of CD94/NKG2C + NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions

Show simple item record

dc.contributor.author Puiggros Metje, Anna Maria
dc.contributor.author Blanco Ares, Gonzalo, 1989-
dc.contributor.author Muntasell i Castellví, Aura, 1972-
dc.contributor.author Rodríguez-Rivera, María
dc.contributor.author Nonell Mazelón, Lara
dc.contributor.author Altadill, Mireia
dc.contributor.author Puigdecanet Riubugent, Eulàlia
dc.contributor.author Arnal, Magdalena
dc.contributor.author Calvo, Xavier
dc.contributor.author Gimeno Vázquez, Eva
dc.contributor.author Abella Monreal, Eugenia
dc.contributor.author Abrisqueta, Pau
dc.contributor.author Bosch José, Francesc Xavier, 1947-
dc.contributor.author Yélamos López, José
dc.contributor.author Ferrer, Ana
dc.contributor.author López-Botet, M. (Miguel)
dc.contributor.author Espinet Solà, Blanca
dc.date.accessioned 2021-09-28T06:19:12Z
dc.date.issued 2021
dc.identifier.citation Puiggros A, Blanco G, Muntasell A, Rodríguez-Rivera M, Nonell L, Altadill M, Puigdecanet E, Arnal M, Calvo X, Gimeno E, Abella E, Abrisqueta P, Bosch F, Yélamos J, Ferrer A, López-Botet M, Espinet B. Reduced expansion of CD94/NKG2C + NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions. Int J Lab Hematol. 2021;43(5):1032-40. DOI: 10.1111/ijlh.13494
dc.identifier.issn 1751-5521
dc.identifier.uri http://hdl.handle.net/10230/48510
dc.description.abstract Introduction: Dysregulated NK cell-mediated immune responses contribute to tumor evasion in chronic lymphocytic leukemia (CLL), although the NK cell compartment in CLL-like monoclonal B-cell lymphocytosis (MBL) is poorly understood. In healthy individuals, human cytomegalovirus (HCMV) induces the expansion of NK cells expressing high levels of CD94/NKG2C NK cell receptor (NKR) specific for HLA-E. Methods: We analyzed the expression of NKG2A, NKG2C, ILT2, KIR, CD161, and CD57 in 24 MBL and 37 CLL. NKG2C was genotyped in these patients and in 81 additional MBL/CLL, while NKG2C gene expression was assessed in 26 cases. In 8 CLL patients with increased lymphocytosis (≥20 × 109 /L), tumor HLA-E and HLA-G expression was evaluated. Results: NKR distribution did not significantly differ between MBL and CLL patients, although they exhibited reduced NKG2C+ NK cells compared with a non-CLL group (4.6% vs 12.2%, P = .012). HCMV+ patients showed increased percentages of NKG2C+ NK cells compared with HCMV- (7.3% vs 2.9%, P = .176). Frequencies of NKG2C deletions in MBL/CLL were similar to those of the general population. Low/undetectable NKG2C expression was found among NKG2C+/- (45%) and NKG2C+/+ (12%) patients. CLL cases with increased lymphocytosis displayed especially reduced NKG2C expression (1.8% vs 8.1%, P = .029) and tumor cells with high HLA-E (>98%) and variable HLA-G expression (12.4%, range: 0.5-56.4). CLL patients with low NKG2C expression (<7%) showed shorter time to first treatment (P = .037). Conclusion: Reduced percentages of CD94/NKG2C+ NK cells were observed in CLL and MBL patients independently of HCMV serostatus and NKG2C zygosity, particularly in CLL patients with increased lymphocytosis, which could potentially be related to the exposure to tumor cells.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartof Int J Lab Hematol. 2021;43(5):1032-40
dc.rights This is the peer reviewed version of the following article: Puiggros A, Blanco G, Muntasell A, Rodríguez-Rivera M, Nonell L, Altadill M, Puigdecanet E, Arnal M, Calvo X, Gimeno E, Abella E, Abrisqueta P, Bosch F, Yélamos J, Ferrer A, López-Botet M, Espinet B. Reduced expansion of CD94/NKG2C + NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions. Int J Lab Hematol. 2021 Feb 22. DOI: 10.1111/ijlh.13494, which has been published in final form at http://dx.doi.org/10.1111/ijlh.13494. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
dc.title Reduced expansion of CD94/NKG2C + NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1111/ijlh.13494
dc.subject.keyword HLA-E
dc.subject.keyword NKG2C
dc.subject.keyword Chronic lymphocytic leukemia
dc.subject.keyword Human cytomegalovirus
dc.subject.keyword Monoclonal B cell lymphocytosis
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking